<?xml version="1.0" encoding="UTF-8"?>
<ref id="B48-pharmaceuticals-13-00096">
 <label>48.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Liu</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Wei</surname>
    <given-names>Q.</given-names>
   </name>
   <name>
    <surname>Lin</surname>
    <given-names>Q.</given-names>
   </name>
   <name>
    <surname>Fang</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Kwok</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Tang</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Nishiura</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Peng</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Tan</surname>
    <given-names>Z.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Antiâ€“spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection</article-title>
  <source>JCI Insight</source>
  <year>2019</year>
  <volume>4</volume>
  <pub-id pub-id-type="doi">10.1172/jci.insight.123158</pub-id>
 </element-citation>
</ref>
